Certified by Founder Lodge 
                                        
                                        Takeda Ventures, Inc.
 
                                                 United States  -  San Diego, CA 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $85,000,000
                                            6 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Ensoma | 
                                                            February, 06 ,2023 | Series B | $85,000,000 | 
   Koneksa | 
                                                            February, 08 ,2022 | Series C | $45,000,000 | 
   OncoResponse | 
                                                            May, 19 ,2023 | Unknown | $14,000,000 | 
   Larkspur Biosciences | 
                                                            May, 24 ,2023 | Unknown | $35,500,000 | 
   Harness Therapeutics | 
                                                            December, 01 ,2023 | Unknown | $5,067,000 | 
   Be Biopharma | 
                                                            October, 23 ,2024 | Unknown | $82,000,000 | 
                                                
  Ensoma
  Koneksa
  OncoResponse
  Larkspur Biosciences
  Harness Therapeutics
  Be Biopharma
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)